Latest News

FDA Approves First-in-Class Zolifodacin for Uncomplicated Gonorrhea
FDA Approves First-in-Class Zolifodacin for Uncomplicated Gonorrhea

December 12th 2025

Zolifodacin is a single-dose oral treatment option for uncomplicated urogenital gonorrhea and one of the first new classes of drugs for the disease in 20 years.

FDA Expands Use of GSK's Gepotidacin as Oral Treatment for Uncomplicated Urogenital Gonorrhea
FDA Expands Use of GSK's Gepotidacin as Oral Treatment for Uncomplicated Urogenital Gonorrhea

December 11th 2025

WHO Safety Panel Updates Evidence Review, Confirms Vaccines Do Not Cause Autism / image credit ©SoniaBonet/stock.adobe.com
WHO Safety Panel Updates Evidence Review, Confirms Vaccines Do Not Cause Autism

December 11th 2025

FDA Opens Safety Review of RSV Monoclonal Antibodies Used in Infants / image credit ©Bork/shutterstock.com
FDA Opens Safety Review of RSV Monoclonal Antibodies Used in Infants

December 10th 2025

New 5-Minute Test Accurately Distinguishes HIV Infection from Vaccine-Induced False Positives
New 5-Minute Test Accurately Distinguishes HIV Infection from Vaccine-Induced False Positives

December 9th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.